Lead Product(s): TT-01025
Therapeutic Area: Hepatology (Liver, Pancreatic, Gall Bladder) Product Name: TT-01025
Highest Development Status: Preclinical Product Type: Small molecule
Partner/Sponsor/Collaborator: LG Chem
Deal Size: $350.0 million Upfront Cash: Undisclosed
Deal Type: Licensing Agreement August 18, 2020
Under the terms of the agreement, LG Chem will obtain exclusive worldwide rights, except Greater China region and Japan, to develop and commercialize TT-01025.